Cancer medicines
Enzalutamide
Enzalutamide
An oral therapy blocking androgen receptor signaling.
Sources checked · Introductory guide
On this page
How it works
It inhibits androgen receptors to limit prostate cancer growth.[3]
Where it is used
Used in selected metastatic, castration-resistant or high-risk biochemical recurrent prostate cancers. Check the endocrine combination for your setting.[1]
Key safety points
Discuss falls, fatigue and drug interactions. Seizures, altered consciousness, chest pain or breathlessness need immediate care.[2]
Questions for your care team
- Do I continue hormone injections, and how are fall and seizure risks assessed?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Enzalutamide (opens in a new tab)
- MedlinePlus · Enzalutamide (opens in a new tab)
- NCI Drug Dictionary · Enzalutamide (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.